Immunosuppressants mortality, and risk of cancer

被引：3

作者：

Avorn, Jerry ^{[1
]}

Schneeweiss, Sebastian ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Cambridge, MA 02138 USA

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2009年 / 339卷

关键词：

D O I：

10.1136/bmj.b1645

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：2

共 10 条

[1]

AVOM J, 2004, POWER MED BENEF RISK

[2] In defense of pharmacoepidemiology - Embracing the yin and yan of drug research [J].

Avorn, Jerry .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (22) :2219-2221

[3]

Baciu A., 2006, The future of drug safety

[4] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].

CHARLSON, ME ;

POMPEI, P ;

ALES, KL ;

MACKENZIE, CR .

JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383

[5] Comorbidity measures for use with administrative data [J].

Elixhauser, A ;

Steiner, C ;

Harris, DR ;

Coffey, RN .

MEDICAL CARE, 1998, 36 (01) :8-27

[6]

KEMPEN JH, 2009, BRIT MED J, V338, pB2480

[7] Evaluating medication effects outside of clinical trials: New-user designs [J].

Ray, WA .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 158 (09) :915-920

[8]

Rothman KJ, 2009, NEW ENGL J MED, V360, P301

[9] Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data [J].

Schneeweiss, S ;

Seeger, JD ;

Maclure, M ;

Wang, PS ;

Avorn, J ;

Glynn, RJ .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 154 (09) :854-864

[10] A review of uses of health care utilization databases for epidemiologic research on therapeutics [J].

Schneeweiss, S ;

Avorn, J .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 2005, 58 (04) :323-337

← 1 →